NAV
$34.29
AUM
$82.2M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.87
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| -7.12% | +0.61% | -1.80% | -1.53% | +5.75% | +2.62% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 3.79% |
| 2 | EDEN.PA | Edenred SE | 3.32% |
| 3 | HAG.DE | Hensoldt AG Ordinary Shares | 3.09% |
| 4 | DSFIR.AS | DSM-Firmenich AG | 3.07% |
| 5 | ABEV3.SA | Ambev SA | 3.06% |
| 6 | JHX | James Hardie Industries PLC | 3.01% |
| 7 | SY1.DE | Symrise AG | 2.99% |
| 8 | NOVO-B.CO | Novo Nordisk AS Class B | 2.75% |
| 9 | 8113.T | Unicharm Corp | 2.74% |
| 10 | UMG.AS | Universal Music Group NV | 2.67% |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is comprised of securities issued by companies that Morningstar, Inc. ("Morningstar") determines have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors ("wide moat companies"). The fund is non-diversified.
Inception Date: 2015-07-13